NutraCast: Improving CBD bioavailability with SmartSorb delivery technology 18-Mar-2022 By Danielle Masterson Regulation of CBD, or lack thereof, is one challenge that the CBD industry faces. Another is bioavailability, which is impacted by quality, delivery method, and pharmacokinetics.
Study: Low turmeric dose delivers higher concentrations 18-Oct-2021 By Danielle Masterson The comparison study from Inventia Nutriventia brand TurmXTRA 60N highlights notable pharmacokinetics.
Pharmacokinetics ought to form basis of evaluating bioavailability claims, expert says 29-Aug-2018 By Hank Schultz Claims of greater bioavailability in the nutraceutical realm are often misapplied or miss the point, according to Nils Hoem, PhD.
